Related Experiment Videos
Multidrug-resistant Enterococcus raffinosus from a decubitus ulcer: a case report.
Vincenzo Savini1, Assunta Manna, Giovanni Di Bonaventura
1Unità Operativa Complessa di Microbiologia e Virologia Clinica, Dipartimento di Medicina Trasfusionale, Ospedale Civile Spirito Santo, Pescara, Italy. vincsavi@yahoo.it
The International Journal of Lower Extremity Wounds
|March 29, 2008
Summary
A decubitus ulcer case revealed multidrug-resistant Enterococcus raffinosus, a rare cause of wound infection. This finding highlights emerging antibiotic resistance and daptomycin
Area of Science:
- Infectious Diseases
- Microbiology
- Clinical Medicine
Background:
- Decubitus ulcers (pressure ulcers) are susceptible to secondary infections.
- Enterococcus species are common causes of healthcare-associated infections.
- Multidrug resistance (MDR) in enterococci complicates treatment options.
Observation:
- A case of decubitus ulcer infection caused by Enterococcus raffinosus is presented.
- The isolate demonstrated resistance to multiple antibiotics, including beta-lactams, gentamicin, and ciprofloxacin.
- This represents the first reported wound infection with an E. raffinosus strain exhibiting this resistance profile.
Findings:
- The study documents a novel instance of antibiotic resistance in Enterococcus raffinosus.
- The specific resistance pattern observed is uncommon for this species.
- Daptomycin demonstrated efficacy in treating the severe, difficult-to-treat enterococcal infection.
Implications:
- This case expands the understanding of antibiotic resistance emergence in less common enterococcal species.
- It underscores the need for vigilant surveillance of antimicrobial resistance patterns.
- Daptomycin is confirmed as a viable therapeutic option for severe enterococcal infections refractory to other treatments.
Related Concept Videos
01:25Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
01:29Staphylococcal Skin Infections
Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
01:25Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
01:30Development of Antibiotic Resistance
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...